# A Randomized Placebo-Controlled Trial of Armodafinil (Nuvigil) for Fatigue in Patients With Malignant Gliomas

> **NCT00766467** · PHASE2 · COMPLETED · sponsor: **Eudocia Quant Lee, MD** · enrollment: 81 (actual)

## Conditions studied

- Malignant Glioma

## Interventions

- **DRUG:** Armodafinil
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT00766467
- **Lead sponsor:** Eudocia Quant Lee, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-09
- **Primary completion:** 2014-07
- **Final completion:** 2014-07
- **Target enrollment:** 81 (ACTUAL)
- **Last updated:** 2016-07-28

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00766467

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00766467, "A Randomized Placebo-Controlled Trial of Armodafinil (Nuvigil) for Fatigue in Patients With Malignant Gliomas". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT00766467. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*